In agreement with this, it has previously been described that in some conditions of muscle wasting (e.g. sarcopenia), there are discrepancies between studies, showing upregulation, downregulation, or no alteration in Atrogin-1/MAFbx and MuRF-1 expression (56). The gene discussed is FBXO32; the disease is sarcopenia.